Zeina A. Nahleh

Zeina A. Nahleh

Hematology Oncology

2950 Cleveland Clinic Boulevard
Weston, FL 33331

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 92 publications

Breast Cancer Follow-Up and Surveillance After Primary Treatment: ASCO Guideline Update.

Breast Cancer Follow-Up and Surveillance After Primary Treatment: ASCO Guideline Update.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 16, 2026

Clinicopathologic and Histologic Determinants of the Oncotype DX Recurrence Score in ER+/HER2- Breast Cancer: AJCC Stage-Matched Comparisons and Predictors of a Very Low Recurrence Score.

Clinicopathologic and Histologic Determinants of the Oncotype DX Recurrence Score in ER+/HER2- Breast Cancer: AJCC Stage-Matched Comparisons and Predictors of a Very Low Recurrence Score.

Journal: Human pathology

Published: May 05, 2026

CLO26-097: Robotic-Assisted Bronchoscopy (RAB) Compared to CT-Guided Transthoracic Biopsy (CTTB) in the Diagnosis of Lung Malignancy.

CLO26-097: Robotic-Assisted Bronchoscopy (RAB) Compared to CT-Guided Transthoracic Biopsy (CTTB) in the Diagnosis of Lung Malignancy.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 29, 2026

CLO26-098: Factors Associated With Tumor Progression in HR+/HER2- Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: A Multi-Center Real-World Experience.

CLO26-098: Factors Associated With Tumor Progression in HR+/HER2- Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: A Multi-Center Real-World Experience.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 16, 2026

CLO26-097: Robotic-Assisted Bronchoscopy (RAB) Compared to CT-Guided Transthoracic Biopsy (CTTB) in the Diagnosis of Lung Malignancy.

CLO26-097: Robotic-Assisted Bronchoscopy (RAB) Compared to CT-Guided Transthoracic Biopsy (CTTB) in the Diagnosis of Lung Malignancy.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 01, 2026

CLO26-098: Factors Associated With Tumor Progression in HR+/HER2- Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: A Multi-Center Real-World Experience.

CLO26-098: Factors Associated With Tumor Progression in HR+/HER2- Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: A Multi-Center Real-World Experience.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 01, 2026

Minimal residual disease in solid tumors: Clinical applications and future directions.

Minimal residual disease in solid tumors: Clinical applications and future directions.

Journal: Cancer

Published: September 30, 2025

Factors associated with developing and surviving brain metastases in patients with breast cancer: a multi-center experience.

Factors associated with developing and surviving brain metastases in patients with breast cancer: a multi-center experience.

Journal: BMC cancer

Published: August 29, 2025

Impact of adjuvant chemotherapy delay on overall survival in early-stage breast cancer: a retrospective analysis.

Impact of adjuvant chemotherapy delay on overall survival in early-stage breast cancer: a retrospective analysis.

Journal: Frontiers in oncology

Published: July 15, 2025

Survival outcomes of neoadjuvant chemoradiation followed by surgery versus definitive chemoradiation in ESCC: real-world data.

Survival outcomes of neoadjuvant chemoradiation followed by surgery versus definitive chemoradiation in ESCC: real-world data.

Journal: Frontiers in oncology

Published: July 02, 2025

CLO25-083: Immune-Related Adverse Events in Women With Early and Advanced Triple-Negative Breast Cancer Treated With Pembrolizumab: A Multi-Center Analysis.

CLO25-083: Immune-Related Adverse Events in Women With Early and Advanced Triple-Negative Breast Cancer Treated With Pembrolizumab: A Multi-Center Analysis.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 29, 2025

CLO25-082: Predictors of Survival in Breast Cancer With Brain Metastases: A Multi-Center Institutional Experience.

CLO25-082: Predictors of Survival in Breast Cancer With Brain Metastases: A Multi-Center Institutional Experience.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 28, 2025

Showing 1-12 of 92

Last Updated: 09/26/2026